オンコロジーNGS市場：技術、製品・サービス、用途別-2025～2030年の世界予測

オンコロジーNGS市場は、2023年に4億3,826万米ドルと評価され、2024年には5億437万米ドルに達すると予測され、CAGR 15.48％で成長し、2030年には12億39万米ドルに達すると予測されています。

がん領域の次世代シーケンサー（NGS）とは、がんゲノムを従来の方法よりも迅速かつ経済的に分析し、個別化がん治療に必要な詳細な知見を提供するために使用される先進的ゲノムシーケンス技術を指します。がん領域におけるNGS市場は、特定の遺伝子変異の同定を可能にし、効果的ながん管理に不可欠な標的治療の調整に役立つことから、精密医療に対する需要の高まりによって牽引されています。この用途は、診断、治療法の決定、患者の進行状況のモニタリングにNGSを利用する病院、研究機関、製薬会社など、さまざまな最終用途に広がっています。市場成長に影響を与える治療要因としては、シーケンスコストを大幅に削減したNGSプラットフォームの技術的進歩、正確な治療戦略を必要とする世界のがん罹患率の上昇、ゲノム研究における政府と民間資金の増加などが挙げられます。しかし、同市場は、データ解釈に伴う複雑性の高さ、厳しい規制の枠組み、NGSラボ設立のための初期投資コストの高さといった課題による制約に直面しています。こうした課題にもかかわらず、NGSデータを管理・解釈するためのバイオインフォマティクス企業との提携や、NGS別の革新的な診断・治療ソリューションにつながる共同研究を通じて、発展的な機会が存在します。さらに、特に新興市場において、既存のインフラのギャップに対処することは、成長の可能性を示します。事業成長のためには、ユーザーフレンドリーなバイオインフォマティクスツールの開発、1回のアッセイでより多くの遺伝子をカバーするためのマルチプレキシング機能の強化、非侵襲的診断ソリューションとしてのリキッドバイオプシー技術の探求など、技術革新の機が熟しているセグメントが挙げられます。市場のダイナミックな性質を考慮すると、最新の技術進歩、規制状況の変化、競合情勢の変化を常に把握しておくことは、機会を特定し、それを捉える上で極めて重要です。全体として、オンコロジーNGSの市場は、機敏な適応と継続的なイノベーションを優先する企業にとって大きな可能性を秘めています。

市場力学：急速に進化するオンコロジーNGS市場の主要市場洞察を公開

オンコロジーNGS市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界のがん罹患率の上昇に起因する潜在的需要
  • 臨床腫瘍学における個別化医療の人気の高まり
  • 遺伝子配列決定ソリューションのコスト低下による消費者導入の増加
• 市場抑制要因
  • データ管理のための計算効率の欠如
• 市場機会
  • 腫瘍学の研究開発セグメントにおける政府の取り組みと投資の増加
  • 全ゲノムシーケンスの世界の進歩
• 市場課題
  • 限られた不十分な償還ポリシー

ポーターのファイブフォース：オンコロジーNGS市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：オンコロジーNGS市場における外部からの影響の把握

外部マクロ環境要因は、オンコロジーNGS市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：オンコロジーNGS市場における競合情勢の把握

オンコロジーNGS市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：オンコロジーNGS市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、オンコロジーNGS市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：オンコロジーNGS市場における成功への道筋を描く

オンコロジーNGS市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界のがん罹患率の上昇により潜在的需要が増加
    • 臨床腫瘍学における個別化医療の人気の高まり
    • 遺伝子配列分析ソリューションのコスト低下により消費者の採用が増加
  • 抑制要因
    • データ管理の計算効率の欠如
  • 機会
    • 腫瘍学の研究開発セグメントにおける政府の取り組みと投資の増加
    • 世界中で全ゲノム配列分析の新たな進歩
  • 課題
    • 限定的で不十分な払い戻しポリシー
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 オンコロジーNGS市場：技術別

• イントロダクション
• アンプリコンベース
• ハイブリッド化ベース
• 対象と遺伝子パネルシーケンス
• 全エクソーム配列分析
• 全ゲノム配列分析

第7章 オンコロジーNGS市場：製品・サービス別

• イントロダクション
• プラットフォームと関連製品
  • 消耗品
  • パネル
  • プラットフォーム
• サービス
  • ワークフロー別
  • NGSデータ分析
  • NGSプレシーケンス
  • NGS一次データ分析
  • NGS二次データ分析
  • NGSシーケンシング
  • NGS三次データ分析

第8章 オンコロジーNGS市場：用途別

• イントロダクション
• 学術研究と臨床研究
• 病院・クリニック
• 製薬とバイオテクノロジー企業

第9章 南北アメリカのオンコロジーNGS市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋のオンコロジーNGS市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのオンコロジーNGS市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 4basecare Onco Solutions Private Limited
• BGI Group
• Caris Life Sciences
• Eurofins Scientific SE
• Foundation Medicine, Inc.
• Genotypic Technology Pvt. Ltd.
• Hologic, Inc.
• MedGenome
• Myriad Genetics, Inc.
• PerkinElmer Inc.
• Premas Life Sciences
• Sayre Therapeutics Pvt Ltd.
• SciGenom Labs Pvt. Ltd.
• Tecan Trading AG
• Vela Diagnostics Holding Pte Ltd.
• Xcelris Labs Ltd.

LIST OF FIGURES

• FIGURE 1. ONCOLOGY NGS MARKET RESEARCH PROCESS
• FIGURE 2. ONCOLOGY NGS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ONCOLOGY NGS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. ONCOLOGY NGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ONCOLOGY NGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ONCOLOGY NGS MARKET DYNAMICS
• TABLE 7. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ONCOLOGY NGS MARKET SIZE, BY AMPLICON-BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HYBRIDIZATION-BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TARGETED & GENE PANEL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PANELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ONCOLOGY NGS MARKET SIZE, BY BY WORKFLOW, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS PRE-SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS PRIMARY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS SECONDARY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS TERTIARY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL ONCOLOGY NGS MARKET SIZE, BY ACADEMIC & CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PHARMA & BIOTECH ENTITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. CANADA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 49. CANADA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 50. CANADA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 51. CANADA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 52. CANADA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. CHINA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. CHINA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 77. CHINA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 78. CHINA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 79. CHINA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. INDIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. INDIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 82. INDIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 83. INDIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 84. INDIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 89. INDONESIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 94. JAPAN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 99. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 104. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 109. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 114. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 119. TAIWAN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 124. THAILAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 129. VIETNAM ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 140. DENMARK ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 145. EGYPT ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 150. FINLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 155. FRANCE ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 160. GERMANY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 165. ISRAEL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. ITALY ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. ITALY ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 168. ITALY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 169. ITALY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 170. ITALY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 175. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 180. NIGERIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 185. NORWAY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. POLAND ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. POLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 188. POLAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 189. POLAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 190. POLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. QATAR ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 192. QATAR ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 193. QATAR ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 194. QATAR ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 195. QATAR ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 200. RUSSIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 205. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 210. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 215. SPAIN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 220. SWEDEN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 225. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 230. TURKEY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 235. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 240. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 241. ONCOLOGY NGS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 242. ONCOLOGY NGS MARKET, FPNV POSITIONING MATRIX, 2023

The Oncology NGS Market was valued at USD 438.26 million in 2023, expected to reach USD 504.37 million in 2024, and is projected to grow at a CAGR of 15.48%, to USD 1,200.39 million by 2030.

Oncology Next-Generation Sequencing (NGS) refers to advanced genomic sequencing technologies used to analyze cancer genomes more swiftly and economically than traditional methods, providing detailed insights necessary for personalized cancer treatment. The NGS market in oncology is driven by the increasing demand for precision medicine, as it allows for the identification of specific genetic mutations and helps tailor targeted therapies, essential for effective cancer management. This application extends across various end uses like hospitals, research institutions, and pharmaceutical companies who utilize NGS for diagnostics, therapy decisions, and monitoring patient progress. Factors influencing market growth include the technological advancements in NGS platforms that have significantly reduced sequencing costs, rising incidences of cancer globally necessitating precise treatment strategies, and increasing government and private funding in genomic research. However, the market faces limitations from challenges such as the high complexity involved in data interpretation, stringent regulatory frameworks, and the high initial investment cost for setting up NGS laboratories. Despite these challenges, evolving opportunities exist through partnerships with bioinformatics companies to manage and interpret NGS data, and through collaborations that lead to innovative NGS-based diagnostic and therapeutic solutions. Furthermore, addressing gaps in the existing infrastructure, especially in emerging markets, presents growth potential. For business growth, areas ripe for innovation include the development of user-friendly bioinformatics tools, enhancement in multiplexing capabilities to cover more genes in a single assay, and the exploration of liquid biopsy technologies as a non-invasive diagnostic solution. Given the dynamic nature of the market, staying informed of the latest technological advancements, regulatory changes, and competitive landscape shifts is crucial for identifying and seizing opportunities. Overall, the market for oncology NGS holds significant promise for businesses that prioritize agile adaptation and continuous innovation.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Oncology NGS Market

The Oncology NGS Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Potential demand attributed to rising prevalence of cancer incidence globally
  • Growing popularity of personalized medicine in clinical oncology
  • Increasing consumer adoption owing to decreasing costs for genetic sequencing solutions
• Market Restraints
  • Lack of computational efficiency for data management
• Market Opportunities
  • Rising governmental initiatives and investments in the field of research and development in oncology
  • Emerging advancements for whole-genome sequencing worldwide
• Market Challenges
  • Limited and inadequate reimbursement policies

Porter's Five Forces: A Strategic Tool for Navigating the Oncology NGS Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Oncology NGS Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Oncology NGS Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Oncology NGS Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Oncology NGS Market

A detailed market share analysis in the Oncology NGS Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Oncology NGS Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Oncology NGS Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Oncology NGS Market

A strategic analysis of the Oncology NGS Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Oncology NGS Market, highlighting leading vendors and their innovative profiles. These include 4basecare Onco Solutions Private Limited, BGI Group, Caris Life Sciences, Eurofins Scientific SE, Foundation Medicine, Inc., Genotypic Technology Pvt. Ltd., Hologic, Inc., MedGenome, Myriad Genetics, Inc., PerkinElmer Inc., Premas Life Sciences, Sayre Therapeutics Pvt Ltd., SciGenom Labs Pvt. Ltd., Tecan Trading AG, Vela Diagnostics Holding Pte Ltd., and Xcelris Labs Ltd..

Market Segmentation & Coverage

This research report categorizes the Oncology NGS Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Amplicon-based, Hybridization-based, Targeted & Gene Panel Sequencing, Whole Exome Sequencing, and Whole Genome Sequencing.
• Based on Product & Service, market is studied across Platforms & Related Products and Services. The Platforms & Related Products is further studied across Consumables, Panels, and Platforms. The Services is further studied across By Workflow, NGS Data Analysis, NGS Pre-Sequencing, NGS Primary Data Analysis, NGS Secondary Data Analysis, NGS Sequencing, and NGS Tertiary Data Analysis.
• Based on Application, market is studied across Academic & Clinical Research, Hospitals & Clinics, and Pharma & Biotech Entities.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Potential demand attributed to rising prevalence of cancer incidence globally
    • 5.1.1.2. Growing popularity of personalized medicine in clinical oncology
    • 5.1.1.3. Increasing consumer adoption owing to decreasing costs for genetic sequencing solutions
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of computational efficiency for data management
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising governmental initiatives and investments in the field of research and development in oncology
    • 5.1.3.2. Emerging advancements for whole-genome sequencing worldwide
  • 5.1.4. Challenges
    • 5.1.4.1. Limited and inadequate reimbursement policies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Oncology NGS Market, by Technology

• 6.1. Introduction
• 6.2. Amplicon-based
• 6.3. Hybridization-based
• 6.4. Targeted & Gene Panel Sequencing
• 6.5. Whole Exome Sequencing
• 6.6. Whole Genome Sequencing

7. Oncology NGS Market, by Product & Service

• 7.1. Introduction
• 7.2. Platforms & Related Products
  • 7.2.1. Consumables
  • 7.2.2. Panels
  • 7.2.3. Platforms
• 7.3. Services
  • 7.3.1. By Workflow
  • 7.3.2. NGS Data Analysis
  • 7.3.3. NGS Pre-Sequencing
  • 7.3.4. NGS Primary Data Analysis
  • 7.3.5. NGS Secondary Data Analysis
  • 7.3.6. NGS Sequencing
  • 7.3.7. NGS Tertiary Data Analysis

8. Oncology NGS Market, by Application

• 8.1. Introduction
• 8.2. Academic & Clinical Research
• 8.3. Hospitals & Clinics
• 8.4. Pharma & Biotech Entities

9. Americas Oncology NGS Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Oncology NGS Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Oncology NGS Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 4basecare Onco Solutions Private Limited
• 2. BGI Group
• 3. Caris Life Sciences
• 4. Eurofins Scientific SE
• 5. Foundation Medicine, Inc.
• 6. Genotypic Technology Pvt. Ltd.
• 7. Hologic, Inc.
• 8. MedGenome
• 9. Myriad Genetics, Inc.
• 10. PerkinElmer Inc.
• 11. Premas Life Sciences
• 12. Sayre Therapeutics Pvt Ltd.
• 13. SciGenom Labs Pvt. Ltd.
• 14. Tecan Trading AG
• 15. Vela Diagnostics Holding Pte Ltd.
• 16. Xcelris Labs Ltd.